Knockdown of Ubiquitin-Specific Protease 53 Enhances the Radiosensitivity of Human Cervical Squamous Cell Carcinoma by Regulating DNA Damage-Binding Protein 2.
Apoptosis
Biomarkers, Tumor
/ genetics
Carcinoma, Squamous Cell
/ genetics
Cell Cycle Checkpoints
Cell Proliferation
DNA-Binding Proteins
/ genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Prognosis
Radiation Tolerance
Survival Rate
Tumor Cells, Cultured
Ubiquitin-Specific Proteases
/ antagonists & inhibitors
Uterine Cervical Neoplasms
/ genetics
DNA binding protein 2
cervical cancer
radiotherapy
sensitivity
ubiquitin-specific protein 53
Journal
Technology in cancer research & treatment
ISSN: 1533-0338
Titre abrégé: Technol Cancer Res Treat
Pays: United States
ID NLM: 101140941
Informations de publication
Date de publication:
Historique:
entrez:
9
6
2020
pubmed:
9
6
2020
medline:
5
1
2021
Statut:
ppublish
Résumé
Cervical cancer ranks fourth in incidence and mortality among women. Ubiquitin-specific protein 53 binds to damage-specific DNA binding protein 2 and affects the biological properties of colon cancer. Damage-specific DNA binding protein is involved in nucleotide excision repair, which can repair DNA damage. However, the mechanism by which ubiquitin-specific protein 53 regulates the radiosensitivity of cervical cancer through damage-specific DNA binding protein remains unclear. Tissue samples from 40 patients with cervical squamous cell carcinoma who received radiotherapy were examined by immunohistochemistry to detect the expression of ubiquitin-specific protein 53, and clinical data were collected for statistical analysis. The cell cycle was detected by flow cytometry in Siha cells transfected with Si-USP53 and exposed to 8 Gy irradiation. Cell viability was determined by the CCK8 method in cells transfected with Si-USP53 and exposed to 0, 2, 4, 6, 8, or 10 Gy. The expression of damage-specific DNA binding protein, cyclin-dependent kinase 1, and cell cycle checkpoint kinase 2 was detected in cells transfected with Si-USP53. The expression of ubiquitin-specific protein 53 in the tissues of patients with cervical squamous cell carcinoma was correlated with the sensitivity to radiotherapy. Knockdown of ubiquitin-specific protein 53 in Siha cells downregulated damage-specific DNA binding protein and caused G2/M cell cycle arrest and decreased the survival rate of cells in response to radiation. Ubiquitin-specific protein 53-induced cell cycle arrest and affected the radiotherapy sensitivity of tumors through damage-specific DNA binding protein.
Sections du résumé
BACKGROUND
Cervical cancer ranks fourth in incidence and mortality among women. Ubiquitin-specific protein 53 binds to damage-specific DNA binding protein 2 and affects the biological properties of colon cancer. Damage-specific DNA binding protein is involved in nucleotide excision repair, which can repair DNA damage. However, the mechanism by which ubiquitin-specific protein 53 regulates the radiosensitivity of cervical cancer through damage-specific DNA binding protein remains unclear.
METHODS
Tissue samples from 40 patients with cervical squamous cell carcinoma who received radiotherapy were examined by immunohistochemistry to detect the expression of ubiquitin-specific protein 53, and clinical data were collected for statistical analysis. The cell cycle was detected by flow cytometry in Siha cells transfected with Si-USP53 and exposed to 8 Gy irradiation. Cell viability was determined by the CCK8 method in cells transfected with Si-USP53 and exposed to 0, 2, 4, 6, 8, or 10 Gy. The expression of damage-specific DNA binding protein, cyclin-dependent kinase 1, and cell cycle checkpoint kinase 2 was detected in cells transfected with Si-USP53.
RESULTS
The expression of ubiquitin-specific protein 53 in the tissues of patients with cervical squamous cell carcinoma was correlated with the sensitivity to radiotherapy. Knockdown of ubiquitin-specific protein 53 in Siha cells downregulated damage-specific DNA binding protein and caused G2/M cell cycle arrest and decreased the survival rate of cells in response to radiation.
CONCLUSION
Ubiquitin-specific protein 53-induced cell cycle arrest and affected the radiotherapy sensitivity of tumors through damage-specific DNA binding protein.
Identifiants
pubmed: 32508265
doi: 10.1177/1533033820929792
pmc: PMC7281878
doi:
Substances chimiques
Biomarkers, Tumor
0
DDB2 protein, human
0
DNA-Binding Proteins
0
USP53 protein, human
EC 3.4.19.12
Ubiquitin-Specific Proteases
EC 3.4.19.12
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1533033820929792Commentaires et corrections
Type : ErratumIn
Références
DNA Repair (Amst). 2016 Jun;42:63-71
pubmed: 27156098
Oncol Res Treat. 2016;39(9):516-20
pubmed: 27614991
Cell Cycle. 2012 Dec 1;11(23):4378-84
pubmed: 23159851
Eur J Pharmacol. 2016 Jan 15;771:77-83
pubmed: 26688569
Oncogene. 2012 May 10;31(19):2373-88
pubmed: 21996736
Dis Esophagus. 2017 Jun 1;30(6):1-7
pubmed: 28475750
Radiat Oncol. 2015 Nov 14;10:227
pubmed: 26572130
EMBO Rep. 2017 Aug;18(8):1318-1330
pubmed: 28623188
J Neurosci. 2015 Nov 25;35(47):15582-98
pubmed: 26609154
Int J Cancer. 2010 Aug 15;127(4):977-88
pubmed: 20013802
Pathol Oncol Res. 2017 Apr;23(2):323-328
pubmed: 27585443
Cancer Cell Int. 2018 May 1;18:64
pubmed: 29743814
Med Sci Monit. 2015 May 05;21:1276-87
pubmed: 25940978
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84
pubmed: 30659131
Cell Death Dis. 2017 Mar 23;8(3):e2693
pubmed: 28333152
Cell Cycle. 2009 Dec 15;8(24):4067-71
pubmed: 19923893
Radiat Environ Biophys. 2017 Mar;56(1):89-98
pubmed: 28184999
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Cancer Res. 2017 Apr;15(4):418-428
pubmed: 28087741
Tumour Biol. 2016 Oct;37(10):14183-14191
pubmed: 27553023
Biochem Biophys Res Commun. 2004 Jan 30;314(1):54-62
pubmed: 14715245